TrialThe journal of allergy and clinical immunology. In practice

Hypereosinophilic Syndrome Subtype Predicts Responsiveness to Glucocorticoids.

Paneez Khoury et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.